Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00948285 · ClinicalTrials.gov registry record · NA
Importance of Magnetic Resonance Imaging (MRI) in Treating Breast Cancer
A NA study, sponsored by Texas Tech University Health Sciences Center.
- Terminated
- Registry status
- NA
- Development phase
- 194
- Enrollment target
NCT00948285: Clinical Trial NA study, sponsored by Texas Tech University Health Sciences Center.
NCT00948285 is a NA study that was terminated before completion, run by Texas Tech University Health Sciences Center. The registered enrollment target is 194 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (86% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00948285, a NA study, was terminated before completion, sponsored by Texas Tech University Health Sciences Center.
- TERMINATED
- Registry status
- NA
- Development phase
- 194 participants
- Enrollment target
Study Summary
The purpose of this study is to determine if the use of magnetic resonance imaging (MRI) for breast cancer translates into better surgical outcomes. MRIs may help ensure that as little healthy tissue is removed as is possible and may help prevent the need for additional surgical procedures.
Interventions
- PROCEDURE MRI
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 194 participants |
| Start Date | 2009-07 |
| Est. Completion | 2018-12 |
| Phase | NA |
Why NCT00948285 stopped before completion
NCT00948285 is an interventional study that assigns participants to a tested intervention. The registered 194 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (86% lower).
The record links to 0 conditions, and to 1 intervention - of which MRI is the first listed.
NCT00948285 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00948285 about?
NCT00948285 is a clinical study titled "Importance of Magnetic Resonance Imaging (MRI) in Treating Breast Cancer". The purpose of this study is to determine if the use of magnetic resonance imaging (MRI) for breast cancer translates into better surgical outcomes. MRIs may help ensure that as little healthy tissue is removed as is possible and may help prevent the need for additional surgical procedures.
What is the current status of trial NCT00948285?
This trial is currently terminated. It is a NA study. The enrollment target is 194 participants. The study started on 2009-07. Estimated completion is 2018-12.
What interventions are being tested in trial NCT00948285?
The interventions under investigation include: MRI (PROCEDURE).
Who is sponsoring clinical trial NCT00948285?
This trial is sponsored by Texas Tech University Health Sciences Center, which has 76 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00948285's enrollment target sits among peer trials
194 568th of 2000 higher than 1,432 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03593759 · 194 participants · Phase 3
Cardiac Sarcoidosis Randomized Trial
- NCT05053152 · 194 participants · Phase 2
Testing the Addition of the Drug Relugolix to the Usual Radiation Therapy for Advanced-Stage Prostate Cancer, The NRG Promethean Study
- NCT05156112 · 194 participants · NA
OSA PAP Treatment for Veterans With SUD and PTSD on Residential Treatment Unit
- NCT05351424 · 194 participants · NA
AVI Didactic Experience for Latinx Patient Treatment Adherence and Non-English Speaker Trial Enrollment Study in Rad Onc
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia